Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: A study employing a new stable isotope breath test

Journal of Lipid Research

Volumn 43, Issue 5, 2002, Pages 706-712

  Chan, Dick C ^a   Watts, Gerald F ^a,c   Hugh R Barrett, P ^a   Martins, Ian J ^a   James, Anthony P ^b   Mamo, John C L ^a   Mori, Trevor A ^a   Redgrave, Trevor G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Dyslipidaemia; HMG CoA reductase inhibitor; Triglyceride rich lipoproteins

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; CARBON 13; CHOLESTEROL; CHOLESTEROL OLEATE; CHYLOMICRON; ISOTOPE; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BREATH ANALYSIS; CATABOLISM; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSLIPIDEMIA; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MEASUREMENT; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTICHOLESTEREMIC AGENTS; BODY MASS INDEX; BREATH TESTS; CARBON DIOXIDE; CARBON ISOTOPES; CHOLESTEROL; CHYLOMICRON REMNANTS; CHYLOMICRONS; DOUBLE-BLIND METHOD; HEPTANOIC ACIDS; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; OBESITY; PLACEBOS; PYRROLES; TIME FACTORS; TRIGLYCERIDES; VISCERA;

EID: 0036245249     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease
2. Postprandial lipoproteins and progression of coronary atherosclerosis
3. Atherosclerosis as a post-prandial disease
4. Postprandial dyslipidaemia in a nutshell: Food for thought
5. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men
6. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: Principle results from EUROASPIRE II Euro Heart Survey
7. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology, service
8. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
9. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the cholesterol and recurrent events (CARE) trial
10. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia
11. Kinetics of triglyceride rich lipoproteins: Chylomicrons and very low density lipoproteins
12. A highly sensitive assay for quantitation of apolipoprotein B-48 using an antibody to human apolipoprotein B and enhanced chemiluminescence
13. Evaluation of an immunoseparation method for the quantitative measurement of remnant-like particle cholesterol in serum and plasma
14. Postprandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B-48 in the fasting state
15. 2 breath test to assess the metabolism of triglyceride-rich lipoprotein remnants in mice
16. Chylomicron remnant metabolism im familial dyslipidemias studied with a remnant-like emulsion breath test
17. Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test
18. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice
19. Sterol side chain length and structure affect the clearance of chylomicron-like lipid emulsions in rats and mice
20. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-1
21. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
22. Direct association between the hepatic secretion of very-low-density, lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man
23. Information theory and an extension of the maximum likelihood principle
24. Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia
25. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion
26. Modulation of chylomicron remnant metabolism by an hepatic hydroxymethyglutaryl coenzyme A reductase inhibitor
27. Atorvastatin improves postprandial lipoprotein metabolism in normolipidemic subjects
28. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: Do statins have a specific effect on triglyceride metabolism?
29. Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease
30. Postprandial plasma vitamin-A metabolism in humans - A reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants
31. Effects of statins on triglyceride metabolism
32. Dyslipidaemia and obesity
33. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes
34. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women
35. In vivo stimulation of low-density lipoprotein degradation by insulin
36. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity
37. Hepatic uptake of chylomicron remnants
38. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects
39. Effect of simvastatin on triglyceride-rich lipoprotein remnant metabolism in patients with heterozygous familial hypercholesterolaemia
40. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: Clinical aspects